Herein, we report a novel truncated form of PDGFRB without a partner protein in B-ALL and confirm its oncogenicity and sensitivity to tyrosine kinase inhibitors (TKIs). This evidence concerns the gene PDGFRB and acute lymphoblastic leukemia.